chartexchange

CADL
Candel Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
5.32USD-1.481%(-0.08)1,389,687
Pre-marketNov 18, 2026 9:26:30 AM EST
5.36USD-0.741%(-0.04)
After-hoursNov 18, 2026 4:00:30 PM EST
5.32USD0.000%(-0.00)
Loading…
Loading…
416.94M
Healthcare
Biotechnology
HQ
Needham, MA, USA
Previous Close
$5.40
Beta
2.20
52-Week High
$14.00 2026-08-27
52-Week Low
$4.35 2025-11-25
SMA 50
$9.33
SMA 200
$8.40
Avg. Vol 10D
2.03M
Avg. Vol 30D
1.40M
Avg. Vol 90D
1.27M
Relative Vol
1.00
62.15M
13,087,782
0.6000%
39,318
CADL Profile

also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.

CADL Performance
PeriodPriceDateChangeBeta
1W8.392026-11-12-36.65%-4.573
1M8.212026-10-19-35.26%2.853
3M13.502026-08-19-60.63%2.711
6M7.662026-05-19-30.61%2.243
1Y4.422025-11-19+20.25%2.203
2Y3.992024-11-19+33.21%—
5Y10.872021-11-19-51.10%1.234
CADL Stock Summary

Candel Therapeutics, Inc. Common Stock (NASDAQ:CADL) stock price today is $5.32, and today's volume is 1,389,687. CADL is down 1.574% today. The 30 day average volume is 1.40M. CADL market cap is $416.94M with 78.45M shares outstanding.